Skip to main content

Featured

Canada's New Grocery Benefit Starts July 3 — How Much Will You Get?

  If you've been receiving the GST/HST credit, something is changing on July 3, 2026 — and it's actually good news. The federal government is replacing the old credit with a new program called the Canada Groceries and Essentials Benefit (CGEB) , and it comes with payments that are 25% larger. More than 12 million Canadians qualify. No application is required. Here's everything you need to know before the first payment lands. What Is the CGEB? The Canada Groceries and Essentials Benefit is the federal government's replacement for the GST/HST credit, which has been around since 1991. Prime Minister Mark Carney announced the new benefit on January 26, 2026, and it received Royal Assent on February 12 under Bill C-19. The legislation commits $11.7 billion in additional support to Canadians over six years — $3.1 billion immediately through the one-time June top-up, and $8.6 billion over five years through higher quarterly payments. The name change is deliberate — it signal...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment